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BACKGROUND: Reactions to uncertainty in clinical
medicine can affect decision making.
OBJECTIVE: To assess the extent to which radiologists’
reactions to uncertainty influence diagnostic mammog-
raphy interpretation.
DESIGN: Cross-sectional responses to a mailed survey
assessed reactions to uncertainty using a well-validated
instrument. Responses were linked to radiologists’
diagnostic mammography interpretive performance
obtained from three regional mammography registries.
PARTICIPANTS: One hundred thirty-two radiologists
from New Hampshire, Colorado, and Washington.
MEASUREMENT: Mean scores and either standard
errors or confidence intervals were used to assess
physicians’ reactions to uncertainty. Multivariable lo-
gistic regression models were fit via generalized esti-
mating equations to assess the impact of uncertainty on
diagnostic mammography interpretive performance
while adjusting for potential confounders.
RESULTS: When examining radiologists’ interpretation
of additional diagnostic mammograms (those after
screening mammograms that detected abnormalities),
a 5-point increase in the reactions to uncertainty score
was associated with a 17% higher odds of having a
positive mammogram given cancer was diagnosed
during follow-up (sensitivity), a 6% lower odds of a
negative mammogram given no cancer (specificity), a
4% lower odds (not significant) of a cancer diagnosis
given a positive mammogram (positive predictive value
[PPV]), and a 5% higher odds of having a positive
mammogram (abnormal interpretation).
CONCLUSION: Mammograms interpreted by radiolo-
gists who have more discomfort with uncertainty have
higher likelihood of being recalled.
KEY WORDS: physician uncertainty; medical malpractice; breast cancer
screening; mammography.
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INTRODUCTION
Studies on mammography interpretive performance indicate
significant variability exists among radiologists.1–4 Sensitivity
of screening and diagnostic mammography range from 72.4–
88.6% to 78.1–85.8%, respectively.5–8 Sources of this variabil-
ity have been attributed to radiologists’ interpretive volume
and years of interpretive experience, but even the most recent
studies on these factors reported conflicting results.9,10 Vari-
ability in interpretive performance, especially in diagnostic
mammography, is an important clinical problem because low
recall rates can result in missed cancer or delay in diagnosis,
whereas high recall rates can lead to unnecessary work-up
with associated costs, patient anxiety, and potential for patient
morbidity.
Several factors may affect radiologists’ thresholds of concern
as they view mammographic images and decide whether the
film is positive, negative, or inconclusive. The practice envi-
ronment is one such factor, as interpreting mammography
occurs in a highly litigious environment in the United States.
Failure or delay in breast cancer diagnosis is the most frequent
medical malpractice allegation in the United States,11 likely
making interpreting mammography quite stressful. One study
in Internal Medicine found that physicians’ reactions to
uncertainty led to excessive resource use.12 In a previous
study,13 we found that reactions to uncertainty, including
stress or anxiety, were associated with sex and years of
interpretive experience but had no affect on interpretive
performance of screening mammography. We concluded that
interpreting screening mammography where cancer detection
rates are quite low, approximately 4 out of 1,000,5–7,14 is not as
stressful as hypothesized. In contrast, diagnostic mammogra-
phy has a reported cancer detection rate of 25 out of 1,000,15
and may be associated with higher levels of stress from
uncertainty than screening mammography.
We used a well-validated instrument16,17 to assess reactions
to uncertainty among radiologists who interpret diagnostic
mammography in three distinct regions in the United States.
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In addition, we explored the extent to which radiologists’
reactions to uncertainty explain variability in interpretive
performance of diagnostic mammography. We hypothesized
that more stressful reactions to uncertainty would be associated
with the likelihood of recalling women for additional work-up.
METHODS
Study Population
Three regional mammography registries participated in this
study: Group Health Cooperative, a nonprofit integrated health
care organization in the Pacific Northwest; the New Hampshire
Mammography Network,18 which captures 90% of women
undergoing mammography in New Hampshire; and the Colo-
rado Mammography Program, which captures approximately
50% of the women in the six-county metropolitan area of
Denver. These three registries are members of the federally
funded Breast Cancer Surveillance Consortium.19 Although
certain characteristics of the registries differ, they represent
the spectrum of health delivery systems providing mammog-
raphy in the U.S. Federal, state and local confidentiality and
data security protections obtained to guard this research data
are described elsewhere.20
Eligible radiologists included those interpreting screening
and diagnostic mammograms around the time of the survey,
identified through the three registries. Radiologists were
excluded if they planned to move or retire during the study
period. After we obtained approval from the Institutional
Review Board of each site, we used mail and telephone
follow-up to recruit eligible radiologists. Subjects were in-
formed that their participation would involve completing a
survey about their demographic, clinical, and other mammog-
raphy-related experience, which would then be linked to their
interpretive performance of mammography as obtained from
their respective registries.
Instrument Development and Data Collection
A detailed description of the radiologist survey and its
psychometric properties is provided elsewhere.13 Briefly, the
survey ascertained sex, years of interpreting mammography,
interpretive volume, reimbursement mechanism, medico-legal
experience, and reactions to uncertainty involved in patient
care. The survey section on reactions to uncertainty, adapted
from an instrument developed by Gerrity et al.,16,17 charac-
terizes physicians’ reactions to uncertainty in three domains:
(1) anxiety from uncertainty, (2) concern about bad outcomes,
and (3) reluctance to disclose information to physician col-
leagues. This analysis is limited to the first 2 domains. The
third was not a significant domain in the analysis. Table 1
outlines the two domains of this analysis and their respective
items as well as means and standard errors as reported by the
radiologists in our sample. Individual items were revised to
make them relevant to the practice of mammography interpre-
tation.13 Radiologists rated items using a 6-point Likert scale
(1=strongly disagree, 2=moderately disagree, 3=slightly dis-
agree, 4=slightly agree, 5=moderately agree, and 6=strongly
agree). An uncertainty score with the 2 domains combined
could range from 8 to 48, with 8 indicating low reactions to
uncertainty and 48 indicating high reactions to uncertainty. A
prior study demonstrated that alpha coefficients for the revised
subscales ranged from 0.69 to 0.89.13 When removing the
third domain the alpha coefficient for the reaction to uncer-
tainty measure was 0.89, indicating a high level of internal
consistency for this measure.
Data Linkages
Survey data were merged with interpretation and outcome data
obtained from the three registries for diagnostic mammograms
that occurred between January 1, 1996 and December 31, 2002
allowing 1 year of follow-up to ascertain a breast cancer
diagnosis (through December 2003). We defined diagnostic
mammograms as (1) additional evaluation performed after a
recent screening mammogram to assess an abnormality, (2)
those performed at short interval to evaluate stability in a
previously detected abnormality, (3) those performed to evaluate
a breast concern that was not reported to be a lump, and (4)
those performed to evaluate a self-reported breast lump. Mam-
mograms of women with breast implants or a history of breast
reconstruction or reduction were excluded from the analysis.
Core variables obtained from each registry included date;
type of mammogram (see above); BI-RADS™ interpretation and
recommendation categories;21 patient demographic, clinical,
and risk characteristics; and breast cancer outcome. Standard-
ized variable definitions allowed for merging of data from
different screening programs while ensuring both uniformity
and confidentiality of all data.16 Linkages between radiologists’
uncertainty scores from the mailed survey and performance
data were made by a centralized data-coordinating center.
Analytic Definitions
Mammograms were considered positive if assigned a final BI-
RADS™ code21 of 0 with a recommendation for biopsy, FNA or
Table 1. Reactions to Uncertainty by Individual Items and Scales
Reaction to uncertainty scales and
individual items
Mean
score*
Standard
error
Anxiety because of uncertainty scale (∝=
0.89)
19.4 0.49
Uncertainty in mammography makes me
uneasy
4.2 0.12
I am quite comfortable with the
uncertainty in mammography practice†
3.9 0.12
I find the uncertainty involved in
mammography disconcerting
3.9 0.12
The uncertainty in mammography often
troubles me
3.6 0.12
I usually feel anxious when I am not sure of a
mammographic interpretation
3.8 0.11
Concern about bad outcomes scale (∝=
0.69)
10.2 0.29
When I am uncertain of a mammographic
interpretation, I imagine all sorts of bad
scenarios—patient dies, patient sues,
etc.
3.0 0.12
I fear being held accountable for the limits of my
knowledge
3.2 0.13
I worry about malpractice when I am not sure of
a mammographic interpretation
4.0 0.12
Items were adapted to mammography practice.
*Based on response scale of 1 (strongly disagree) to 6 (strongly agree).
†Item is reverse scored.
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surgical consult, 4 (suspicious abnormality) or 5 (highly
suggestive of cancer) at the end of the imaging work-up. The
most severe interpretation of either breast on a bilateral
mammogram was used to classify the overall assessment. We
classified mammograms as negative if assigned a BI-RADS™
code of 1 (negative), 2 (benign finding), 3 (probably benign), or
0 without a recommendation for biopsy.
The follow-up period for cancer outcomes associated with
each examination was 365 days. Breast pathology outcomes
(benign and malignant) were identified through pathology data
banks and/or regional cancer registries. Only invasive breast
cancer and ductal carcinoma in situ cases were included.
Lobular carcinoma in situ cases were excluded because they
are not visible on mammography.
Analytic Calculations and Statistical Analysis
Examinations were false positive when the assessment was
positive and a breast cancer diagnosis did not occur within the
follow-up period (365 days). Examinations were true positive
when the assessment was positive and a cancer diagnosis
followed. A false negative examination was a negative assess-
ment with a diagnosis of cancer within the follow-up period. A
true negative examination was a negative assessment with no
subsequent cancer diagnosis within the follow-up period.
Sensitivity was calculated as true positive/(true positive+false
negative). Specificity was calculated as true negative/(true
negative+false positive). Positive predictive value (PPV) was
calculated as true positive/(true positive+false positive). Recall
rate was calculated as positive examinations/(positive exam-
inations+negative examinations).
Performance measures may vary among the 4 types of
diagnostic mammograms described above.15 Therefore, analy-
ses were stratified by type of diagnostic mammogram. Analyses
examining sensitivity, specificity, and PPV were based on
radiologists interpreting diagnostic mammograms (of a specific
type) resulting in breast cancers or not. Each radiologist
characteristic was initially examined univariately with respect
to the combined uncertainty scale as well as the individual
subscale. The means and 95% confidence intervals (CI) were
computed for each scale by radiologist characteristic. Statisti-
cally significant differences between means were assessed
using the SAS procedure GLM.22
For each type of diagnostic mammogram, we used a
multivariable analysis to examine the association between
the combined reactions to uncertainty scale (as well as the 2
subscales) and each performance measurement. The analysis
adjusted for mammography registry, radiologist sex, age, and
interpretive volume. We also adjusted for patient age at
mammogram and time since last mammogram. Odds ratios
were used to quantify the influence of these variables on the
probability of a true positive or true negative outcome.
The combined uncertainty score was divided by 5 for ease of
interpretation of the odds ratios. Thus, we are able to discuss
the changes in the odds of a positive mammogram, negative
mammogram, or cancer diagnosis associated with a 5-point
change in reactions to uncertainty score. We undertook this
approach for 2 reasons. First, a 5-point increase represents an
approximate 17% change in score based on our mean
uncertainty score of 30, felt to be more reflective of clinically
relevant change than a 1-point increase. We used this
approach in our prior paper on uncertainty in screening
Table 2. Physician Characteristics by Level of Uncertainty (Includes 132 Radiologists with Diagnostic Mammograms During 1996–2002)
Number of radiologists Percent Anxiety because of
uncertainty
Concern about bad
outcomes
Combined uncertainty
score
Mean 95% CI Mean 95% CI Mean 95% CI
Physician characteristics
Overall 132 19.4 (18.4–20.3) 10.2 (9.7–10.8) 29.6 (28.2–31.0)
Sex
Male 102 77.9 19.9 (18.8–21.0) 10.6 (10.0–11.2) 30.5 (28.9–32.1)
Female 29 22.1 17.4 (15.4–19.4) 9.0 (7.8–10.3) 26.4 (23.4–29.5)
Years of interpretation
≤9 30 22.9 20.8 (18.9–22.7) 11.0 (9.8–12.3) 31.9 (29.0–34.8)
10–19 59 45.0 19.2 (17.7–20.6) 10.6 (9.7–11.4) 29.7 (27.7–31.8)
≥20 42 32.1 18.9 (17.0–20.7) 9.3 (8.3–10.4) 28.2 (25.4–30.9)
Interpretive volume
<500 4 3.1 20.0 (11.1–28.9) 11.0 (5.5–16.5) 31.0 (16.9–45.1)
500–1,000 32 24.6 20.6 (18.6–22.5) 11.4 (10.2–12.6) 32.0 (29.0–35.0)
1,001–2,000 49 37.7 19.4 (17.7–21.1) 9.9 (8.9–10.9) 29.3 (26.8–31.9)
2,001–5,000 40 30.8 18.7 (17.0–20.4) 9.8 (8.8–10.8) 28.5 (26.1–30.9)
>5,000 5 3.9 16.2 (8.5–23.9) 8.8 (4.7–12.9) 25.0 (14.6–35.4)
Method of reimbursement
Annual set salary 45 34.4 19.9 (18.4–21.4) 10.6 (9.5–11.6) 30.4 (28.2–32.7)
Per mammogram 5 3.8 16.4 (10.4–22.4) 9.2 (6.0–12.4) 25.6 (18.4–32.8)
Shared partnership profits 71 54.2 19.6 (18.4–20.9) 10.4 (9.7–11.2) 30.1 (28.2–32.0)
Some combination 10 7.6 17.5 (11.3–23.7) 8.4 (5.3–11.5) 25.9 (17.1–34.7)
Medical practice–related law suit*
Any 69 52.3 19.9 (18.6–21.3) 10.5 (9.8–11.3) 30.4 (28.5–32.4)
None 63 47.7 18.8 (17.4–20.2) 9.9 (9.0–10.8) 28.7 (26.6–30.8)
Items in bold show statistically significant differences at P<.05 level.
CI=confidence interval.
*Not necessarily mammography-related.
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mammography interpretation,13 and wanted to make compar-
isons between our findings for screening and diagnostic
mammograms. Each diagnostic mammogram was associated
with an assessment and breast cancer outcome. Therefore, the
analysis was performed at the mammogram level but
accounted for the correlation within each radiologist. Logistic
regression models were fit using generalized estimating equa-
tions,23 assuming an independent working correlation matrix
to account for potential correlation among mammograms
interpreted by the same radiologist. For all analyses, tests
were two-sided with P values ≤.05 considered to be statistically
significant.
RESULTS
One hundred and eighty-one eligible radiologists were invited
to participate by completing the survey. Of these, 139 con-
sented and completed all or a portion of the survey for a
response rate of 76.8%. One hundred and thirty-two partici-
pating radiologists (95% of those who completed the survey)
interpreted diagnostic mammograms during the time period
and had complete responses on the reactions to uncertainty
scale.
Table 2 outlines the mean uncertainty scores with 95% CI
by demographic and practice characteristics of participants.
The majority of radiologists were male (78%), most had 10 or
more years of experience (77%), and there was a fairly even
distribution across annual interpretive volume (screening
and/or diagnostic) categories of 500–5,000, with very few
(7%) interpreting more or less than these categories. Most
radiologists were reimbursed through shared partnership
profits or through annual set salary with few being reimbursed
per screening mammogram. Approximately half (52.3%)
reported a prior medical malpractice lawsuit. Only 14% (19/
132) reported a previous mammography-related lawsuit (data
not shown).
The mean reactions to uncertainty score with the two
domains combined was 29.6 (95% CI, 28.2–31.0) of a total
possible score of 48 (Table 2). Scores were lower among female
versus male radiologists (26.4 vs 30.5; P=.018) (Table 2).
Radiologists with more years interpreting mammography and
higher interpretive volume had slightly lower uncertainty
scores. A test for trend indicated that the reduction in
uncertainty scores with higher years of interpretation was
borderline statistically significant (P=.058). This was especially
significant for reduction in concern about bad outcomes and
higher years of interpretation (P=.03). Method of reimburse-
ment was not associated with uncertainty scores. Radiologists
reporting any prior medico-legal experience had slightly higher
uncertainty scores (30.4 vs 28.7), although this was not
significant.
Performance data linked to survey responses included a
mean of 996 diagnostic mammograms per radiologists (range
Figure 1. Radiologist sensitivity and specificity by uncertainty scores (based on mammograms performed as additional evaluations).
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1–5,285) in the study time period. Of the 131,482 diagnostic
mammograms included in the analysis, 3,080 were true
positive examinations, 120,991 were true negative examina-
tions, 6,470 were false positive examinations, and 941 were
false negatives.
Figures 1 and 2 illustrate the relationship between overall
uncertainty scores and performance measures based on diag-
nostic mammograms that were additional evaluations per-
formed after a recent screening mammogram to assess an
abnormality. The trend line on each figure is based on
predictive probabilities obtained from unadjusted logistic re-
gression models. Higher uncertainty scores are associated with
higher sensitivity (P=.0013) and lower specificity (P=.0015)
(Fig. 1). Similarly, higher uncertainty scores are associated with
higher recall (abnormal interpretation rate; P=.0006) (Fig. 2).
The inverse relationship between uncertainty scores and PPV is
not statistically significant (P=.13).
Table 3 illustrates the results of the multivariable analysis
after adjustments for mammography registry, radiologist char-
acteristics, and patient characteristics. When examining radi-
ologists’ interpretation of additional evaluations after a recent
mammogram, after adjustment a 5-point increase in reactions
to uncertainty was associated with a 17% higher odds of
having a positive mammogram given cancer was diagnosed
during follow-up (sensitivity), a 6% lower odds of a negative
mammogram given no cancer (specificity), a 4% lower odds
(not significant) of a cancer diagnosis given a positive mam-
mogram (PPV), and a 5% higher odds of having a positive
mammogram (abnormal interpretation). Similar relationships
were found within the other subtypes of diagnostic mammo-
grams, although the associations were not usually statistically
significant. Results were unchanged after additionally adjust-
ing for whether the radiologist had a prior medical malpractice
lawsuit.
DISCUSSION
Radiologists who are more bothered by the uncertainty
inherent in clinical medicine have higher recall rates, lower
specificity, and lower PPV in diagnostic mammography inter-
pretation when the diagnostic mammogram was done to
evaluate an abnormality found on a recent screening mammo-
gram. It appears that this type of diagnostic mammogram
generates more concern among radiologists than other types of
diagnostic mammograms. Perhaps this is because of the
equivocal nature of a new finding versus tracking a prior
finding, which is usually assessed for stability. These radiolo-
gists also appear to have higher sensitivity, a finding that is
consistent across all subtypes of diagnostic mammograms.
After adjusting for radiologist factors, within additional evalua-
tions a 5-point increase in reactions to uncertainty was
associated with a 17% higher odds of having a positive
mammogram given cancer, a 5% higher odds of having a
Figure 2. Radiologist PPV and abnormal interpretation rate by uncertainty scores (based on mammograms performed as additional
evaluations).
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diagnostic mammogram interpreted as positive (abnormal
interpretation), a 6% lower odds of having a diagnostic
mammogram accurately interpreted as negative, a 4% lower
odds (not significant) of detecting a cancer when the mammo-
gram was interpreted as positive (PPV).
We conducted this study in an attempt to identify specific
factors affecting radiologists’ interpretive thresholds in higher
stakes mammography interpretation, which might be amena-
ble to change. Identifying these might then lead to a better
understanding of how to modify these factors to enhance
interpretive accuracy. Reducing unnecessary recall in the
United States, while maintaining sensitivity, could result in
both significant cost savings24 and a reduction in the anxiety
women experience when receiving an abnormal mammograph-
ic interpretation.25–27
The high likelihood of cancer in women obtaining diagnostic
mammography might trigger an affective reaction among
radiologists who are less comfortable with possibly missing
an important finding on mammography. Interestingly, our
previous study13 found no association between reactions to
uncertainty and interpretive performance or decision making
in screening mammography. A previously published paper
from this study28 indicated that radiologists have mispercep-
tions about breast cancer risk in the women for whom they
interpret mammograms. We are currently conducting a study
to determine whether we can help radiologists recalibrate their
thresholds of concern by educating them about risk of breast
cancer in their patient populations and about their own risk of
medical malpractice.
Other important questions to address in intervention re-
search include the following: Would double reading policies
reduce uncomfortable reactions to uncertainty? Would certain
radiologists be more likely to benefit from double reading than
others? Will the ability to obtain supplemental consultation
reduce negative reactions to uncertainty? Why does sex of the
radiologist appear to play a significant role in stress associated
with uncertainty? We hope to address several of these ques-
tions in our next study, which may assist us in determining
how to improve interpretive performance.
One concern raised by our study is the relationship between
uncertainty in clinical decision making and physician burn-
out. Radiologists in our study reported high reactions to
uncertainty as well as a high desire to leave the field of
mammography.29 Two previous studies have shown that
Table 3. Adjusted Odds of Various Mammographic Diagnostic Interpretations by Uncertainty Score
Sensitivity Specificity Positive predictive
value
Odds of abnormal
interpretation
Odds of a positive
mammogram
given a cancer
diagnosis during
follow-up
Odds of a negative
mammogram
given no cancer
diagnosis during
follow-up
Odds of cancer
diagnosis given a
positive
mammogram
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Additional evaluation*
Anxiety because of uncertainty score (every 5-point
increase)
1.29 (1.11, 1.50) 0.93 (0.85, 1.02) 0.94 (0.85, 1.03) 1.06 (0.98, 1.14)
Concern about bad outcomes score (every 5-point
increase)
1.21 (0.89, 1.66) 0.85 (0.75, 0.97) 0.93 (0.81, 1.05) 1.14 (1.03, 1.26)
Combined uncertainty score (every 5-point increase) 1.17 (1.05, 1.31) 0.94 (0.89, 0.99) 0.96 (0.90, 1.01) 1.05 (1.01, 1.10)
Short interval follow-up†
Anxiety because of uncertainty score (every 5-point
increase)
1.10 (0.89, 1.35) 0.95 (0.84, 1.08) 1.07 (0.92, 1.25) 1.06 (0.94, 1.19)
Concern about bad outcomes score (every 5-point
increase)
1.20 (0.87, 1.65) 1.08 (0.91, 1.29) 1.11 (0.90, 1.37) 0.95 (0.81, 1.12)
Combined uncertainty score (every 5-point increase) 1.08 (0.94, 1.25) 0.99 (0.91, 1.08) 1.05 (0.95, 1.17) 1.02 (0.94, 1.10)
Evaluation of breast problem (no known lump‡)*
Anxiety because of uncertainty score (every 5-point
increase)
0.95 (0.80, 1.12) 1.00 (0.90, 1.12) 1.01 (0.89, 1.15) 1.00 (0.92, 1.09)
Concern about bad outcomes score (every 5-point
increase)
0.84 (0.61, 1.16) 1.08 (0.93, 1.26) 0.98 (0.81, 1.17) 0.92 (0.83, 1.03)
Combined uncertainty score (every 5-point increase) 0.94 (0.83, 1.07) 1.02 (0.94, 1.10) 1.00 (0.91, 1.10) 0.98 (0.93, 1.04)
Evaluation of beast problem (lump‡)*
Anxiety because of uncertainty score (every 5-point
increase)
1.11 (0.93, 1.32) 0.88 (0.79, 0.98) 0.90 (0.80, 1.01) 1.08 (1.00, 1.17)
Concern about bad outcomes score (every 5-point
increase)
0.92 (0.71, 1.2) 0.88 (0.75, 1.03) 0.85 (0.73, 0.98) 1.05 (0.92, 1.19)
Combined uncertainty score (every 5-point increase) 1.04 (0.92, 1.17) 0.92 (0.85, 0.99) 0.92 (0.85, 0.99) 1.05 (0.99, 1.10)
Items in bold show statistically significant differences at P<.05 level.
CI=confidence interval, OR=odds ratio.
*Models adjusted by mammography registry, radiologist age, radiologist volume (>1,000 vs ≤1,000), radiologist sex, patient age, and time since last
mammogram.
†Models adjusted by mammography registry, radiologist age, radiologist volume (>1,000 vs ≤1,000), radiologist sex, patient age; not adjusted for time
since last mammogram because of lower number of observations in this subtype of diagnostic mammogram.
‡Self-reported symptom as indicated by the woman undergoing the mammogram.
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negative responses to uncertainty or ambiguity among psy-
chologists and primary care providers are associated with
burnout.30,31 The recent Institute of Medicine Report, Improv-
ing Breast Imaging Quality Standards,32 identified several
workforce concerns regarding available radiologists to inter-
pret mammography. Their findings indicate that as the
population of women over age 40 increases by nearly 50%,
the number of radiologists per 10,000 women in the same age
group is expected to decline by 14% in 2015 and 23% by
2025.32 Thus, understanding the relationship between dis-
comfort with uncertainty and performance is important if it is
causing radiologists to discontinue mammography interpreta-
tion. More research is needed to understand this phenomenon
more fully.
No study is without limitations. Our study population
included a representative sample of radiologists practicing in
three distinct regions of the United States. Although our high
response rate allows us to generalize to other radiologists in
these regions, it does not allow us to generalize to radiologists
around the country. The strengths of our study include a high
response rate to a mailed survey, the ability to link well-
validated responses to this survey to actual interpretive
performance data, and inclusion of the breadth of settings
where mammography is performed, including community-
based, academic, and open as well as single-payer health
maintenance organizations. Although this allows us to capture
mammography interpretative practice as it is commonly
performed in the United States, we were not able to conduct
analyses by specific practice settings, such as among radiolo-
gists whose practice is confined specifically to mammography
interpretation, as this was not common in our study popula-
tion. A final potential limitation is that some radiologists had a
sensitivity of 0, which is probably because those radiologists
interpreted a small number of examinations and because
breast cancer is relatively rare, thus, no cancers were detected
in their small samples. Because the analysis was conducted at
the level of the mammogram (not at the level of the provider),
there is no need to repeat the analyses while excluding
radiologists who had outlier values for sensitivity.
In conclusion, mammograms interpreted by radiologists
who have more discomfort with uncertainty have higher
likelihood of being recalled. Interventions should be designed
to address uncertainty in clinical practice when it is found to
affect clinical performance.
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